Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
J Med Primatol ; 42(2): 89-100, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23311598

RESUMO

BACKGROUND: FTY720 is an immunomodulatory agent that reduces lymphocytes in peripheral tissues and circulation. Such agents may be effective as vaginal microbicides for HIV prevention. Systemic or vaginal application of FTY720 may reduce lymphocyte concentrations in genital tissues, reducing HIV target cell numbers. METHODS: Five female pigtail macaques received topical vaginal gel FTY720 (n = 2), intravenous (i.v.) FTY720 (n = 2), or placebo gel (n = 1) in this pilot study. Circulating and mucosal lymphocytes and genital mucosa, cytokines, and tissue histology were analyzed to document topical and i.v. FTY720 effects. RESULTS: Topical and i.v. FTY720 appeared to decrease the levels of cervicovaginal IL-8, IL-1ra, and genital inflammatory cells. Small sample size precluded statistical analysis. Topical administration had no overt adverse effects. CONCLUSIONS: This study introduces FTY720 as an immunomodulatory agent for the vaginal mucosa, compares topical effects to those of i.v. administration, and provides the basis for future studies involving FTY720 for HIV prevention.


Assuntos
Contagem de Linfócitos , Macaca nemestrina , Propilenoglicóis/administração & dosagem , Esfingosina/análogos & derivados , Vagina/efeitos dos fármacos , Vagina/imunologia , Administração Intravaginal , Administração Intravenosa , Animais , Anti-Infecciosos , Colo do Útero/química , Colo do Útero/efeitos dos fármacos , Colo do Útero/imunologia , Avaliação Pré-Clínica de Medicamentos , Feminino , Cloridrato de Fingolimode , Infecções por HIV/prevenção & controle , Imunossupressores , Proteína Antagonista do Receptor de Interleucina 1/análise , Interleucina-8/análise , Mucosa/química , Mucosa/efeitos dos fármacos , Mucosa/imunologia , Projetos Piloto , Placebos , Propilenoglicóis/efeitos adversos , Esfingosina/administração & dosagem , Esfingosina/efeitos adversos , Vagina/química , Cremes, Espumas e Géis Vaginais
3.
Colloids Surf B Biointerfaces ; 60(1): 12-8, 2007 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-17628449

RESUMO

The temperature dependence of Langmuir monolayers of normal and cancerous human cervical tissues and their organic phases between temperatures of 37 and 45 degrees C was evaluated. Analysis of the surface pressure-area isotherms revealed significantly different increase in fluidity of the cancerous cervical tissue monolayer at 42 degrees C as opposed to the normal cervical tissue monolayers (p<0.05). Similarly, in the case of cervical cancerous organic phase monolayers significant increase of fluidity was observed at 40 degrees C whereas no such change was observed in the normal cervical organic phase monolayers. The effect of temperature was found to be different in cancerous and normal cervical tissues and this may be due to the different lipid profiles in them. Cancerous cervical tissues had 1.8-fold higher total lipids as compared to the normals. Similarly, the PC, PE, PI, PG, SM and PS levels in cancerous cervical tissues were 3.6, 2.0, 2.3, 4.7, 1.7 and 2.2 times higher than those of normal cervical tissues, respectively. Significant cancer-normal difference in minimum surface tension and hysteresis area was found at all temperatures studied for both tissue homogenates and organic phases. For example, cancerous tissue homogenates showed minimum surface tensions of 51.9+/-4.6, 54.4+/-5.9, 57.6+/-6.0 and 51.9+/-5.6mN/m at temperatures 37, 40, 42 and 45 degrees C whereas the corresponding values for normal cervical tissue homogenates were 39.3+/-3.6, 39.2+/-3.7, 39.2+/-3.8 and 39.1+/-3.6, respectively. The fluidity change at hyperthermic range of temperature can be correlated to the increased efficiency of drug on combination therapy with hyperthermia. These results may have implications in manipulating the fluidity of cervical cancer tissue membranes for better permeability thereby leading to better therapeutic strategies for cervical cancer.


Assuntos
Colo do Útero/química , Lipídeos/química , Temperatura , Extratos de Tecidos/química , Membrana Celular/química , Feminino , Humanos , Hipertermia Induzida , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/terapia
4.
Artigo em Inglês | MEDLINE | ID: mdl-9849651

RESUMO

In the second part of this study, the emphasis is on the free fatty acids during cervical carginogenesis, since they may reflect active cell metabolism during this disease process. Lipids were extracted from biopsies of normal epithelial tissue (N) (n=36), cervical intraepithelial lesions (CIL) (n=47), and infiltrating lesions (Ca) (n=47) of the cervix. Samples, from which the free fatty acid compositions were determined, were saponified, methylated and analysed by GLC. In accordance with results obtained on total fatty acid compositions, essential fatty acid deficiency (EFAD) in the intraepithelial lesions, compared with normal tissue (linoleic acid, P< 0.01), and infiltrating lesions compared with intraepithelial lesions (linoleic acid and arachidonic acid, P< 0.01) were observed. High levels of oleic acid were also observed when infiltrating lesions were compared with normal tissue (P < 0.01). As previously mentioned by us in part I of this study, with regard to possible disturbances in metabolic pathways based on the total fatty acid profiles during stages of cervical cancer, EFAD is prevalent during cervical carcinogenesis. This EFAD in cancer cells may result in many defective cell mechanisms, since fatty acids are associated with biochemical events such as lipid peroxidation, signal transduction and immune responses. The high level of oleic acid in cancer cells is known to activate PKC and thus contribute to the continous growth stimulus thought to exist in malignant cells. From a therapeutic viewpoint, substantial changes in the fatty acid composition of the membranes can be produced in cancer cells by selective fatty acid supplementation strategies. At present, modifications of the fatty acid compositions of cell membranes represent an experimental model that has promoted increased understanding of lipid transportation, membrane remodelling, and the relationship between membrane lipids and membrane function. By addressing factors responsible for insufficient essential fatty acid levels, carginogenesis may be prevented or treated. The clinical feasibility of using modification of fatty acids in tumours or cancer by diet or perfusion as an adjunct to standard therapies should be tested.


Assuntos
Colo do Útero/química , Ácidos Graxos não Esterificados/análise , Neoplasias do Colo do Útero/metabolismo , Ácidos Graxos Monoinsaturados/análise , Feminino , Humanos , Ácidos Esteáricos/análise
5.
Am J Obstet Gynecol ; 171(1): 77-83, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8030737

RESUMO

OBJECTIVE: The purpose of this study was to determine whether cervical ripening can be induced in rabbits by interleukin-8. STUDY DESIGN: Nonpregnant and pregnant rabbits were treated for 5 days with vaginal suppositories containing 100 ng of interleukin-8. Collagen and glycosaminoglycan concentration in the cervices were assessed histologically by picrosirius red and alcian blue, and the mean optical density was calculated. The mean neutrophil count in five random fields was calculated from each biopsy specimen. RESULTS: Interleukin-8 induced softening and dilatation of the rabbit cervices. Water content was significantly increased (p < 0.0001 and p < 0.001, respectively). Cervical collagen concentration was found to be significantly decreased (p < 0.0004 and p < 0.0001, respectively). Glycosaminoglycan concentration was significantly increased in nonpregnant and pregnant cervices (p < 0.0009 and p < 0.1, respectively). The mean number of neutrophils was significantly increased (p < 0.0005 and p < 0.006, respectively). CONCLUSION: Interleukin-8 can induce cervical ripening in nonpregnant and pregnant rabbits.


Assuntos
Colo do Útero/efeitos dos fármacos , Interleucina-8/uso terapêutico , Trabalho de Parto Induzido/métodos , Animais , Colo do Útero/anatomia & histologia , Colo do Útero/química , Colágeno/análise , Feminino , Glicosaminoglicanos/análise , Interleucina-8/farmacologia , Contagem de Leucócitos , Neutrófilos , Gravidez , Coelhos , Água/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA